Therefore, the present study has undertaken to investigate the gene and protein level expression of KAI-1 in the tissues of breast cancer and benign breast disease and correlated with the clinicopathological parameters of breast cancer. The gene discussed is CD82; the disease is breast fibrocystic disease.